Karim Fizazi, MD, PhD - Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/MOC/AAPA/IPCE information, and to apply for
credit, please visit us at PeerView.com/ZXT865. CME/MOC/AAPA/IPCE
credit will be available until March 13, 2026.


Precision Medicine Crafts a New Story for Metastatic Prostate
Cancer: The Next Act of Therapeutic Intensification With AKT
Inhibition and Beyond


In support of improving patient care, PVI, PeerView Institute for
Medical Education, is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis activity is supported by an
independent educational grant from AstraZeneca.


Disclosure information is available at the beginning of the video
presentation.